Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research
- 7 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 66 (7) , 1140-1146
Abstract
Clinical trials with adaptive designs use data that accumulate during the course of the study to modify study elements in a prespecified manner. The goal is to provide flexibility such that a trial can serve as a definitive test of its primary hypothesis, preferably in a shorter time period, involving fewer human subjects, and at lower cost. Elements that may be modified include the sample size, end points, eligible population, randomization ratio, and interventions. Accumulating data used to drive these modifications include the outcomes, subject enrollment (including factors associated with the outcomes), and information about the application of the interventions. This review discusses the types of adaptive designs for clinical trials, emphasizing their advantages and limitations in comparison with conventional designs, and opportunities for applying these designs to healthcare epidemiology research, including studies of interventions to prevent healthcare-associated infections, combat antimicrobial resistance, and improve antimicrobial stewardship.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- NIH (UM1 AI104681)
This publication has 44 references indexed in Scilit:
- A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosisBMC Medical Research Methodology, 2013
- Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshopClinical Trials, 2012
- Outcome-Adaptive Randomization: Is It Useful?Journal of Clinical Oncology, 2011
- Understanding the FDA Guidance on Adaptive Designs: Historical, Legal, and Statistical PerspectivesJournal of Biopharmaceutical Statistics, 2010
- Adaptive Methods: Telling “The Rest of the Story”Journal of Biopharmaceutical Statistics, 2010
- Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical TrialsStatistics in Biopharmaceutical Research, 2009
- Sample Size Re-Estimation for Adaptive Sequential Design in Clinical TrialsJournal of Biopharmaceutical Statistics, 2008
- A Randomized Trial Evaluating Prosaptide™ for HIV-Associated Sensory Neuropathies: Use of an Electronic Diary to Record Neuropathic PainPLOS ONE, 2007
- When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical TrialPLoS Clinical Trials, 2007
- Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working GroupJournal of Biopharmaceutical Statistics, 2006